Takeda sales, net profit up but targets hauled back
This article was originally published in Scrip
Executive Summary
Takeda, the largest pharmaceutical company in Asia, has reported profits below company guidance and analyst consensus, although acquisitions helped sales grow in the fiscal year ended 31 March.